Get the Stockscreener App
13.42
0.75%
0.104
Sotera Health Co stock is traded at $13.42, with a volume of 2.07M.
It is up +0.75% in the last 24 hours and down -21.61% over the past month.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
See More
Previous Close:
$13.32
Open:
$13.41
24h Volume:
2.07M
Relative Volume:
0.92
Market Cap:
$3.82B
Revenue:
$1.16B
Net Income/Loss:
$77.95M
P/E Ratio:
49.52
EPS:
0.2711
Net Cash Flow:
$144.80M
1W Performance:
-8.46%
1M Performance:
-21.61%
6M Performance:
-16.39%
1Y Performance:
+18.13%
1-Day Range:
$13.29
$13.75
1-Week Range:
$13.22
$14.79
52-Week Range:
$9.53
$19.85
Sotera Health Co Stock (SHC) Company Profile
Name
Sotera Health Co
Sector
Industry
Phone
440-262-1410
Address
9100 SOUTH HILLS BLVD, SUITE 300, BROADVIEW HEIGHTS
Compare SHC vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SHC
Sotera Health Co
|
13.43 | 3.79B | 1.16B | 77.95M | 144.80M | 0.2711 |
|
TMO
Thermo Fisher Scientific Inc
|
469.29 | 176.79B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
186.08 | 131.71B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
569.23 | 45.48B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.46 | 31.55B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
284.90 | 27.79B | 3.17B | 642.63M | 516.49M | 10.77 |
Sotera Health Co Stock (SHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-09-26 | Resumed | RBC Capital Mkts | Outperform |
| Dec-18-25 | Initiated | William Blair | Outperform |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| May-05-25 | Upgrade | Goldman | Neutral → Buy |
| Dec-06-24 | Initiated | Goldman | Neutral |
| May-21-24 | Initiated | Piper Sandler | Neutral |
| Apr-03-24 | Upgrade | Citigroup | Neutral → Buy |
| Mar-25-24 | Upgrade | Jefferies | Hold → Buy |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Sector Weight |
| Jun-26-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-23-23 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-11-23 | Upgrade | Barclays | Underweight → Overweight |
| Jan-11-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Nov-15-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Oct-05-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-26-22 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-21-22 | Downgrade | JP Morgan | Overweight → Underweight |
| Sep-20-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-09-22 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Mar-03-22 | Downgrade | Jefferies | Buy → Hold |
| Mar-02-22 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-14-21 | Initiated | Robert W. Baird | Outperform |
| Dec-15-20 | Initiated | Citigroup | Buy |
| Dec-15-20 | Initiated | Credit Suisse | Outperform |
| Dec-15-20 | Initiated | Goldman | Buy |
| Dec-15-20 | Initiated | JP Morgan | Overweight |
| Dec-15-20 | Initiated | Jefferies | Buy |
| Dec-15-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Dec-15-20 | Initiated | RBC Capital Mkts | Outperform |
View All
Sotera Health Co Stock (SHC) Latest News
Sotera Health at Barclays Conference: Strategic Growth and Legal Challenges - Investing.com
Sotera Health Board Member Trades $229.05M In Company Stock - Benzinga
Insider Transaction: WARBURG PINCUS CO Sells $229.05M Worth Of Sotera Health Shares - Benzinga
Sotera Health Company (NASDAQ:SHC) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Sotera Health stockholders sell 25 million shares in secondary offering - Investing.com India
Sotera Health stockholders sell 25 million shares in secondary offering By Investing.com - Investing.com Canada
Sotera Health Ownership Shift As 25m Share Sale Tests Valuation - simplywall.st
Sotera Health (NASDAQ:SHC) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Wells Fargo Manages Offering for SHC - GuruFocus
Sotera Health shares fall 4.2% as private equity firms launch secondary offering By Investing.com - Investing.com South Africa
Sotera Health shares fall 4.2% as private equity firms launch secondary offering - Investing.com
Sotera Health Up 30% This Past Year, so Why Did One Fund Sell $4 Million in Shares? - AOL.com
Sotera Health (SHC) Launches 25 Million Share Secondary Offering - GuruFocus
Form 424B7 Sotera Health Co - StreetInsider
Warburg Pincus and GTCR affiliates to sell 25M Sotera Health shares - Stock Titan
SHC SEC FilingsSotera Health Co 10-K, 10-Q, 8-K Forms - Stock Titan
Sotera Health Company (SHC) Stock Analysis: Exploring a 30% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Sotera Health (SHC) Loses 13% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Finviz
Assessing Sotera Health (SHC) Valuation After Strong 2025 Results And 2026 Growth Guidance - simplywall.st
Sotera Health (SHC) Is Down 7.1% After Issuing 2026 Revenue Guidance And Marking 20th Growth Year - simplywall.st
SHC Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
SHC Should I Buy - Intellectia AI
Panel: Investors Failed To Show Sterilization Facility Owner Committed Fraud - Law360
FRAUD AND MANIPULATION—6th Cir.: Sterigenics class action dismissal affirmed by the Sixth Circuit - VitalLaw.com
Sotera Health wins appeal of investor lawsuit - Crain's Cleveland
Sotera Health is Now Oversold (SHC) - Nasdaq
Sotera Prevails in Investor Appeal of Emissions Disclosures Suit - Bloomberg Law News
Sotera Health: Strengthening Fundamentals, Margin Expansion, and Deleveraging Support Buy Rating and $20 Target - TipRanks
Sotera Health Company (NASDAQ:SHC) Q4 2025 Earnings Call Transcript - Insider Monkey
Sotera Health Company (SHC) Stock Analysis: A 16.85% Potential Upside In Healthcare Diagnostics - DirectorsTalk Interviews
Earnings call transcript: Sotera Health beats Q4 2025 EPS forecasts - Investing.com Australia
Decoding Sotera Health Co (SHC): A Strategic SWOT Insight - GuruFocus
6th Circ. Affirms Dismissal Of Sotera Toxic Gas Investor Suit - Law360
Sotera Health Q4 2025 slides: 20th year of growth, margins hit 51% - Investing.com Australia
SHC: Citigroup Maintains "Buy" Rating, Raises Price Target to $2 - GuruFocus
Sotera Health (SHC) Margin Expansion To 6.7% Tests Premium 60.9x P/E Narrative - simplywall.st
Sotera Health Co (SHC) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Market Challenges - GuruFocus
SHC Reports Strong Q4 Revenue, Exceeds Expectations - GuruFocus
SHC's Strong Q4 Revenue Surpasses Expectations with Robust Growt - GuruFocus
Sotera Health reports Q4 adjusted EPS 26c, consensus 24c - TipRanks
Sotera Health Q4 2025 slides: 20th year of growth, margins hit 51% By Investing.com - Investing.com South Africa
Sotera Health earnings beat by $0.02, revenue topped estimates - Investing.com Nigeria
Sotera Health Co reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Sotera Health beats Q4 2025 EPS forecasts By Investing.com - Investing.com Canada
Sotera Health General Counsel Alex Dimitrief to transition to outside advisor - TipRanks
Sotera Health (NASDAQ:SHC) Issues Quarterly Earnings Results - MarketBeat
Sotera Health (SHC) Announces Leadership Transition in Legal Dep - GuruFocus
SHC Projects Revenue and Earnings Growth for the Year - GuruFocus
Sotera Health Company's (NASDAQ:SHC) Q4 CY2025: Beats On Revenue - Finviz
Sotera Health (NASDAQ:SHC) Issues FY 2026 Earnings Guidance - MarketBeat
Stronger 2025 lifts Sotera Health (NASDAQ: SHC) guidance for 2026 - Stock Titan
Sotera Health Co Stock (SHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.77%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):